Raj Shah Overview
- Firm
- Nordic Capital
- Primary Position
-
Partner & Head...
- Primary Industry
-
Healthcare
- Active Board Seats
-
1
- Med. Deal Size
-
- Med. Valuation
-
Raj Shah General Information
Biography
Mr. Raj Shah serves as Partner and Head of Healthcare at Nordic Capital. He also serves as a Board Member at Advanz Pharma. He joined in May 2015 and is based in London with a focus on healthcare investments. Prior to joining, he worked as an investment banker and most recently was Co-Head of European Healthcare Investment Banking at Goldman Sachs where he worked since 2004 and led the team that has been involved in several pivotal transactions that have helped shape the healthcare landscape, including Nordic Capital's successful exit of specialty pharmaceutical firm Nycomed. He originally trained as a cardiac surgeon in Oxford and London and holds undergraduate and post graduate degrees from Imperial College London and London Business School as well as being Fellow of the Royal College of Surgeons. He received an MBA from London Business School and an undergraduate degree from The Royal College of Surgeons of England.
Contact Information
Address
- The Marq, 6th Floor
- 32 Duke Street, Saint James
- London SW1Y 6DF
- England, United Kingdom
Raj Shah Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Nordic Capital | Investor | Partner & Head of Healthcare | Copenhagen, Denmark | PE/Buyout |
Raj Shah Board Seats (1)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| Advanz Pharma | Pharmaceuticals | Privately Held (backing) | Private Equity-Backed | London, United Kingdom |
Raj Shah Lead Partner on Deals (10)
Raj Shah has been the lead partner on 10 deals. Their latest deal was with Bayer (Global Rights of Androcur), a buildings and property company. The deal was made on 31-Mar-2024.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Bayer (Global Rights of Androcur) | 31-Mar-2024 | Buyout/LBO | Completed | Buildings and Property | Germany | |
| Timber Pharmaceuticals | 01-Dec-2023 | Completed | Pharmaceuticals | Madison, WI | ||
| Tostran | 17-Oct-2023 | Completed | Pharmaceuticals | Tokyo, Japan | ||
| Sanofi (Hospital Anti-infective Portfolio) | 30-Sep-2022 | Completed | Buildings and Property | Paris, France | ||
| Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) | 01-Jul-2022 | Completed | Drug Discovery | Canada | ||
| Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) | 01-Jul-2022 | Completed | Buildings and Property | New York, NY | ||
| LEO Pharma | 22-Jul-2021 | Completed | Pharmaceuticals | Ballerup, Denmark | ||
| Advanz Pharma | 01-Jun-2021 | Completed | Pharmaceuticals | London, United Kingdom | ||
| Bioclinica | 28-Apr-2021 | Buyout/LBO | Completed | Other Pharmaceuticals and Biotechnology | Princeton, NJ | |
| ArisGlobal | 31-Jul-2019 | Buyout/LBO | Completed | Discovery Tools (Healthcare) | Waltham, MA |
Raj Shah Network (172)
Board Members (45)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Itzhak Krinsky Ph.D | Advanz Pharma | Self | London, United Kingdom | |
| Heather Mason | ConvaTec | Self | London, United Kingdom | |
| Advanz Pharma | Self | London, United Kingdom | ||
| Advanz Pharma | Self | London, United Kingdom | ||
| Advanz Pharma | Self | London, United Kingdom |
Portfolio Executives (101)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Joseph Lucchese | Timber Pharmaceuticals | Chief Financial Officer | 01-Dec-2023 | Madison, WI |
| Joerg Moeller MD | LEO Pharma | Interim Chief Development Officer & Interim Executive Vice President | 22-Jul-2021 | Ballerup, Denmark |
| LEO Pharma | Chief Financial Officer & Executive Vice President, Global Finance and Business Services | 22-Jul-2021 | Ballerup, Denmark | |
| LEO Pharma | Executive Vice President of Global Research & Development | 22-Jul-2021 | Ballerup, Denmark | |
| LEO Pharma | Corporate Vice President - Head of Corporate Strategy | 22-Jul-2021 | Ballerup, Denmark |
Fund Team Members (26)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Andreas Näsvik | Nordic Capital | Nordic Capital Fund X | Copenhagen, Denmark |
| Andreas Näsvik | Nordic Capital | Nordic Capital Fund IX | Copenhagen, Denmark |
| Nordic Capital | Copenhagen, Denmark | ||
| Nordic Capital | Copenhagen, Denmark | ||
| Nordic Capital | Copenhagen, Denmark |
Raj Shah Affiliated Funds (3)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| Nordic Capital Fund IX | Nordic Capital | Buyout | Closed | 2018 | ||||
| Nordic Capital Fund X | Nordic Capital | Buyout | Closed | 2020 | ||||
| Nordic Capital Fund VIII | Nordic Capital | Buyout | Fully Invested | 2013 |
Raj Shah FAQs
-
Who is Raj Shah?
Mr. Raj Shah serves as Partner and Head of Healthcare at Nordic Capital.
-
How much does Raj Shah typically invest?
Raj Shah's median deal size is .
-
What is Raj Shah’s main position?
Raj Shah’s primary position is Partner & Head of Healthcare.
-
What are the contact details for Raj Shah?
Raj Shah’s email address is ra and his phone number is +44 020 .
-
How many active board seats does Raj Shah hold?
Raj Shah holds a board seat in Advanz Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
